The hidden effects of opioid use on the endocrine system

Wide areas of the pharmaceutical industry are ripe for AI-driven enhancement, as examples from the industry’s top innovators reflect. Credit: Shutterstock. With 2025 well underway,

Ar­row­head Phar­ma­ceu­ti­cals has un­veiled high­ly an­tic­i­pat­ed pan­cre­ati­tis re­sults from a late-phase tri­al of ploza­sir­an for a rare lipid dis­or­der, sev­er­al months af­ter re­port­ing topline da­ta